medigraphic.com
Academia Mexicana de Neurología, A.C.

2018, Número 6

<< Anterior Siguiente >>

Rev Mex Neuroci 2018; 19 (6)


Retraso global del desarrollo y la discapacidad intelectual: revisión de la literatura médica

González-Castillo Z, Meneses V, Piña-Aguilar RE

Idioma: Español
Referencias bibliográficas: 44
Paginas: 43-52
Archivo PDF: 270.54 Kb.


RESUMEN

El retraso global del desarrollo (RGD) y la discapacidad intelectual (DI) constituyen problemáticas a las que los profesionales del área de la salud se enfrentan con frecuencia. La mayoría de los trastornos intelectuales se diagnostican durante o después de la etapa escolar. Es de vital importancia conocer los criterios diagnósticos de ambas entidades, identificar los datos clínicos clave que permitan derivar a los pacientes con los especialistas adecuados y realizar una evaluación eficiente. Existen guías prácticas publicadas por consensos internacionales que proveen información relacionada con el abordaje diagnóstico de los pacientes con RGD o DI; sin embargo, su aplicación es muchas veces difícil debido a las limitaciones de costo, eficacia y disponibilidad de los estudios. Presentamos una revisión actualizada de la literatura médica sobre el RGD y la DI. Desde una perspectiva internacional, también hemos tomado en cuenta los artículos que abordan las recomendaciones y los consensos de las organizaciones profesionales. Consideramos su relevancia para el contexto geográfico, particularmente en los países latinos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Tassé MJ, Luckasson R, Schalock RL. The relation between intellectual functioning and adaptative behavior in the diagnosis of intellectual disability. Intellect Dev Disabil. 2016;54(6):381-90.

  2. Moeschler JB, Shevell M; Committee on Genetics. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics. 2014;134(3):e903-18.

  3. Boat TF, Wu JT. National Academies for Sciences, Engineering, and Medicine. Mental disorders and disabilities among low-income children. Washington, DC: The National Academies Press; 2015.

  4. Hodapp RM, Urbano RC, So SA. Using an epidemiological approach to examine outcomes affecting young children with Down syndrome and their families. Downs Syndr Res Pract. 2006;10(2):83-93.

  5. Van Naarden BK, Christensen D, Doernberg N, Schieve L, Rice C, Wiggins L, et al. Trends in the prevalence of autism spectrum disorder, cerebral palsy, hearing loss, intellectual disability, and vision impairment, metropolitan atlanta, 1991-2010. PLoS One. 2015;10: 30124120.

  6. Weiss R. Intellectual disability and developmental disorders in children. En: Weiss R. Introduction to abnormal child and adolescent psychology. 3.a ed. Los Ángeles, CA: SAGE Publications; 2017. p. 88-126.

  7. La discapacidad en México, datos al 2014. México: Instituto Nacional de Estadística y Geografía; 2016.

  8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed). Arlington, VA: American Psychiatric Publishing; 2013.

  9. Verdugo-Alonso MA, Arias-Martínez B, Guillén-Martín VM, Vicente-Sánchez E. La escala de intensidad de apoyos para niños y adolescentes (SIS-C) en el contexto español. Siglo Cero: Revista Española sobre Discapacidad Intelectual. 2014;45:24-40.

  10. Child Development: Developmental Monitoring and Screening. Centers for Disease Control and Prevention (CDC). [Acceso en febrero de 2017]. Disponible en: https://www.cdc.gov/ncbddd/childdevelopment/screening. htlm)

  11. Comisión Nacional de Protección Social en Salud. Manual para la evaluación de menores de cinco años con riesgo de retraso en el desarrollo. 1.a ed. México, D.F.: Secretaría de Salud; 2013.

  12. Reed RA, Snyder D. A Review of Instruments Used In the Assessment of Children. Pennsylvania Psychological Convention. 2014.

  13. Anderson PJ, Burnett A. Assessing developmental delay in early childhood- concerns with the Bayley-III scales. Clin Neuropsychol. 2017;31(2): 371-81.

  14. Bagnato SJ, Macey M, Salaway J, Lehman C. Research foundations for conventional tests and testing to ensure accurate and representative early intervention eligibility. Pittsburgh, PA: Children´s Hospital of Pittsburg of UPMC; Early Childhood Partnerships-TRACE Center for Excellence, and US Department of Education, Office of Special Education Programs; 2007. p. 1-48.

  15. Schonaut L, Salinas P, Armijo I, Schonstedt M, Álvarez J, Manríquez O. Validación de un cuestionario autoadministrado para la evaluación del desarrollo psicomotor. Rev Chil Pediatr. 2009;80:513-9.

  16. Singh A, Jung Yeh C, Boone Blanchard S. Ages and Stages Questionnaire: a global screening scale. Bol Med Hosp Infant Mex. 2017;74(1):5-12.

  17. Council on Children With Disabilities; Section on Developmental Behavioral Pediatrics; Bright Futures Steering Committee; Medical Home Initiatives for Children With Special Needs Project Advisory Committee. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics. 2006;118(1):405-20.

  18. Márquez-Caraveo ME, Zanabria-Salcedo M, Pérez-Barrón V, Aguirre- García E, Arciniega-Buenrostro L, Galván-García CS. Epidemiología y manejo integral de la discapacidad intelectual. Salud Mental. 2011; 34:443-9.

  19. Wechsler D. WISC-IV Escala Wechsler de inteligencia para niños-IV: manual técnico, versión estandarizada. 1.a ed. México, DF: Manual Moderno; 2007.

  20. Sánchez-Escobedo P, Esquivel-Ancona F, Hollingworth L. Intellectual assessment of children and youth in Mexico: past, present, and future. International Journal of School & Educational Psychology. 2016;4:247-53.

  21. Wechsler Intelligence Scale for Children. 5.a ed. en español; 2017. Disponible en: https://www.pearsonclinical.com/psychology/products/ 100001936/wechsler-intelligence-scale-for-children-fifth-edition- spanish.html#tab-details

  22. Syeda MM, Climie EA. Test review: Wechsler Preschool and Primary Scale of Intelligence-Fourth Edition. L Psychoeduc Assess. 2014;32:265-72.

  23. Matute E, Inozemtseva O, González-Reyes AL, Chamorro Y. La evaluación neuropsicológica infantil (ENI): historia y fundamentos teóricos de su validación. Un acercamiento práctico a su uso y valor diagnóstico. Revista de Neuropsicología, Neuropsiquiatría y Neurociencias. 2014;14:68-95.

  24. Ostrosky-Solís F, Gómez-Pérez E, Matute E, Rosselli M, Ardila A, Pineda D. NEUROPSI ATTENTION AND MEMORY: a neuropsychological test battery in Spanish with norms by age and educational level. Appl Neuropsychol. 2007;14(3):156-70.

  25. Yáñez-Téllez G, Prieto-Corona D. Batería neuropsicológica para la evaluación de los trastornos del aprendizaje Baneta. México, DF: Manual Moderno; 2013.

  26. Flores-Lázaro JC, Ostrosky-Solís F, Lozano A. Batería de funciones frontales y ejecutivas: presentación. Revista de Neuropsicología, Neuropsiquiatría y Neurociencia. 2008;8:141-58.

  27. Ray-Subramanian CE, Huai N, Weismer SE. Brief report: adaptative and cognitive skills for toddlers on the autism spectrum. J Autism Dev Disord. 2011;41(5):679-84.

  28. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 2010; 88(12):1008-16.

  29. Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL, et al. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet. 2009;85(4):503-14.

  30. Karam SM, Riegel M, Segal SL, Félix TM, Barros AJ, Santos IS, et al. Genetic causes of intellectual disability in a birth cohort: a population-based study. Am J Med Genet A. 2015;167(6):1204-14.

  31. Srour M, Shevell M. Genetics and the investigation of developmental delay/intellectual disability. Arch Dis Child. 2014;99(4):386-99.

  32. Shevell M, Ashwal S, Donley D, Flint J, Gingold M, Hirtz D, et al. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standars Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology. 2003;60(3):367-80.

  33. Battaglia A, Doccini V, Bernardini L, Novelli A, Loddo S, Capalbo A, et al. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. Eur J Paediatr Neurol. 2013;17(6):589-99.

  34. Michelson DJ, Shevel MI, Sherr EH, Moeschler JB, Gropman AL, Ashwal S. Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standars Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2011;77(17): 1629-35.

  35. Van Karnebeek CD, Shevell M, Zschocke J, Moeschler JB, Stockler S. The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource. Mol Genet Metab. 2014;111(4):428-38.

  36. Eun SH, Hahn SH. Metabolic evaluation of children with global developmental delay. Korean J Pediatr. 2015;58(4):117-22.

  37. Griffiths PD, Batty R, Warren D, Hart A, Sharrard M, Mordekar SR, et al. The use of MR imaging and spectroscopy of the brain in children investigated for developmental delay: what is the most appropriate imaging strategy? Eur Radiol. 2011;21(9):1820-30.

  38. Jauhari P, Boggula R, Bhave A, Bhargava R, Singh C, Kohli N, et al. Aetiology of intellectual disability in paediatric outpatients in Northern India. Dev Med Child Neurol. 2011;53(2):167-72.

  39. Poretti A, Blaser SI, Lequin MH, Fatemi A, Meoded A, Northington FJ, et al. Neonatal neuroimaging findings in inborn errors of metabolism. J Magn Reson Imaging. 2013;37(2):294-312.

  40. Ibrahim M, Parmar HA, Hoefling N, Srinivasan A. Inborn errors of metabolism: combining clinical and radiological clues to solve the mystery. Am J Roentgenol. 2014;203(3):315-27.

  41. Murias K, Moir A, Myers KA, Liu I, Wei XC. Systematic review of MRI findings in children with developmental delay or cognitive impairment. Brain Dev. 2017;39(8):644-55.

  42. Barkovich AJ. An approach to MRI of metabolic disorders in children. J Neuroradiol. 2007;34(2):75-88.

  43. Sherr EH, Shevell MI. Global developmental delay and intellectual disability. En: Swaiman´s pediatric neurology principles and practice. 6.ª ed. Elsevier; 2018. p. 418-23.

  44. Council on Children with Disabilities and Medical Home Implementation Project Advisory Committee. Patient-and family-centered care coordination: a framework for integrating care for children and youth across multiple systems. Pediatrics. 2014;133(5):1451-60.




2020     |     www.medigraphic.com